L1000CDS2: LINCS L1000 characteristic direction signatures search engine

npj Systems Biology and Applications

Volumn 2, Issue , 2016, Pages

  Duan, Qiaonan ^a   Reid, St Patrick ^b   Clark, Neil R ^a   Wang, Zichen ^a   Fernandez, Nicolas F ^a   Rouillard, Andrew D ^a   Readhead, Ben ^a   Tritsch, Sarah R ^b   Hodos, Rachel ^a   Hafner, Marc ^c   Niepel, Mario ^c   Sorger, Peter K ^c   Dudley, Joel T ^a   Bavari, Sina ^b   Panchal, Rekha G ^b   Ma’Ayan, Avi ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b UNITED STATES ARMY MEDICAL RESEARCH INSTITUTE OF INFECTIOUS DISEASES   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85020403526     PISSN: None     EISSN: 20567189     Source Type: Journal    
DOI: 10.1038/npjsba.2016.15     Document Type: Article

References (34)

1. Stegmaier, K. et al. Gene expression–based high-throughput screening (GE-HTS) and application to leukemia differentiation. Nat. Genet. 36, 257–263 (2004).
2. Lamb, J. et al. The Connectivity Map: using gene-expression signatures to connect small molecules, genes, and disease. Science 313, 1929–1935 (2006).
3. Campillos, M., Kuhn, M., Gavin, A.-C., Jensen, L. J. & Bork, P. Drug target identification using side-effect similarity. Science 321, 263–266 (2008).
4. Clark, N. R. et al. The characteristic direction: a geometrical approach to identify differentially expressed genes. BMC Bioinformatics 15, 79 (2014).
5. Smyth, G. K. in Bioinformatics and Computational Biology Solutions Using R and Bioconductor 397–420 (Springer, 2005).
6. Anders, S. Analysing RNA-Seq data with the DESeq package. Mol. Biol. 43, 1–17 (2010).
7. Tusher, V. G., Tibshirani, R. & Chu, G. Significance analysis of microarrays applied to the ionizing radiation response. Proc. Natl Acad. Sci. USA 98, 5116–5121 (2001).
8. McLauchlan, H., Elliott, M. & Cohen, P. The specificities of protein kinase inhibitors: an update. Biochem. J. 371, 199–204 (2003).
9. Kanehisa, M. & Goto, S. KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 28, 27–30 (2000).
10. Ashburner, M. et al. Gene Ontology: tool for the unification of biology. Nature Genet. 25, 25–29 (2000).
11. Lachmann, A. et al. ChEA: transcription factor regulation inferred from integrating genome-wide ChIP-X experiments. Bioinformatics 26, 2438–2444 (2010).
12. Consortium, E. P. The ENCODE (ENCyclopedia of DNA elements) project. Science 306, 636–640 (2004).
13. Lachmann, A. & Ma’ayan, A. KEA: kinase enrichment analysis. Bioinformatics 25, 684–686 (2009).
14. Chen, E. Y. et al. mRNA profiling linked to multiple upstream regulatory layers. Bioinformatics 28, 105–111 (2012).
15. Isik, Z., Baldow, C., Cannistraci, C. V. & Schroeder, M. Drug target prioritization by perturbed gene expression and network information. Sci. Rep. 5, 17417 (2015).
16. Barretina, J. et al. The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity. Nature 483, 603–607 (2012).
17. Yen, J. Y. et al. Therapeutics of ebola hemorrhagic fever: whole-genome transcriptional analysis of successful disease mitigation. J. Infect. Dis. 204, S1043–S1052 (2011).
18. Wahl-Jensen, V. et al. Ebola virion attachment and entry into human macrophages profoundly effects early cellular gene expression. PLoS Negl. Trop. Dis. 5, e1359 (2011).
19. Rasmussen, A. L. et al. Host genetic diversity enables Ebola hemorrhagic fever pathogenesis and resistance. Science 346, 987–991 (2014).
20. Panchal, R. G. et al. Reduced levels of protein tyrosine phosphatase CD45 protect mice from the lethal effects of Ebola virus infection. Cell Host Microbe 6, 162–173 (2009).
21. Rubins, K. et al. The temporal program of peripheral blood gene expression in the response of nonhuman primates to Ebola hemorrhagic fever. Genome Biol. 8, R174 (2007).
22. Chen, E. Y. et al. Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool. BMC Bioinformatics 14, 128 (2013).
23. Gu, H., Ding, L., Xiong S.-d., Gao X.-m. & Zheng, B. Inhibition of CDK2 promotes inducible regulatory T-cell differentiation through TGFβ-Smad3 signaling pathway. Cell Immunol. 290, 138–144 (2014).
24. Zhong, Z., Wen, Z. & Darnell, J. Stat3: a STAT family member activated by tyrosine phosphorylation in response to epidermal growth factor and interleukin-6. Science 264, 95–98 (1994).
25. Dugo, L. et al. in Sepsis: New Insights, New Therapies: Novartis Foundation Symposium 280 128–146 (Wiley Online Library, 2007).
26. Bertsch, S., Lang, C. H. & Vary, T. C. Inhibition of GSK-3β activity with lithium in vitro attenuates sepsis-induced changes in muscle protein turnover. Shock (Augusta, GA) 35, 266 (2011).
27. Claus, C. & Liebert, U. G. A renewed focus on the interplay between viruses and mitochondrial metabolism. Arch. Virol. 159, 1267–1277 (2014).
28. Bowen, E. et al. The effect of interferon on experimental Ebola virus infection in rhesus monkeys. Interferon 5, 5 (1978).
29. Kunick, C., Lauenroth, K., Leost, M., Meijer, L. & Lemcke, T. 1-Azakenpaullone is a selective inhibitor of glycogen synthase kinase-3β. Bioorg. Med. Chem. Lett. 14, 413–416 (2004).
30. Breitling, R., Armengaud, P., Amtmann, A. & Herzyk, P. Rank products: a simple, yet powerful, new method to detect differentially regulated genes in replicated microarray experiments. FEBS Lett. 573, 83–92 (2004).
31. Law, V. et al. DrugBank 4.0: shedding new light on drug metabolism. Nucleic Acids Res. 42, D1091–D1097 (2014).
32. Wang, Z., Clark, N. R. & Ma’ayan, A. Dynamics of the discovery process of protein-protein interactions from low content studies. BMC Syst. Biol. 9, 26 (2015).
33. Law, V. et al. DrugBank 4.0: shedding new light on drug metabolism. Nucleic Acids Res. 42, D1091–D1097 (2014).
34. Schomburg, K., Ehrlich, H. C., Stierand, K. & Rarey, M. From structure diagrams to visual chemical patterns. J. Chem. Inf. Model. 50, 1529–1535 (2010).